Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) Shares Outstanding (Diluted Average) (2021 - 2025)

Q32 Bio (QTTB) has 5 years of Shares Outstanding (Diluted Average) data on record, last reported at $12.3 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 27.51% year-over-year to $12.3 million; the TTM value through Dec 2025 reached $12.3 million, up 27.51%, while the annual FY2025 figure was $12.3 million, 27.51% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $12.3 million in Q4 2025 per QTTB's latest filing, up from $12.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $57.9 million in Q1 2022 and bottomed at $344623.0 in Q1 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $26.5 million, with a median of $12.2 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): plummeted 99.4% in 2023, then soared 3338.63% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $55.3 million in 2021, then increased by 3.83% to $57.4 million in 2022, then plummeted by 99.39% to $349060.0 in 2023, then surged by 2666.77% to $9.7 million in 2024, then increased by 27.51% to $12.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $12.3 million in Q4 2025, $12.2 million in Q3 2025, and $12.2 million in Q2 2025.